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Abstract
Purpose High-fat, high-calorie (HFHC) diets have been used as a model to investigate lipid-induced insulin resistance. 
Short-term HFHC diets reduce insulin sensitivity in young healthy males, but to date, no study has directly compared males 
and females to elucidate sex-specific differences in the effects of a HFHC diet on functional metabolic and cardiovascular 
outcomes.
Methods Eleven males (24 ± 4 years; BMI 23 ± 2 kg.m−2; V ࡆO2 peak 62.3 ± 8.7 ml.min−1.kg−1FFM) were matched to 10 
females (25 ± 4 years; BMI 23 ± 2 kg.m−2; V ࡆO2 peak 58.2 ± 8.2 ml.min−1.kg−1FFM). Insulin sensitivity, measured via oral 
glucose tolerance test, metabolic flexibility, arterial stiffness, body composition and blood lipids and liver enzymes were 
measured before and after 7 days of a high-fat (65% energy) high-calorie (+ 50% kcal) diet.
Results The HFHC diet did not change measures of insulin sensitivity, metabolic flexibility or arterial stiffness in either 
sex. There was a trend towards increased total body fat mass (kg) after the HFHC diet (+ 1.8% and + 2.3% for males and 
females, respectively; P = 0.056). In contrast to females, males had a significant increase in trunk to leg fat mass ratio (+ 5.1%; 
P = 0.005).
Conclusion Lean, healthy young males and females appear to be protected from the negative cardio-metabolic effects of a 
7-day HFHC diet. Future research should use a prolonged positive energy balance achieved via increased energy intake and 
reduced energy expenditure to exacerbate negative metabolic and cardiovascular functional outcomes to determine whether 
sex-specific differences exist under more metabolically challenging conditions.
Keywords High-fat · High-calorie · Metabolic health · Sex differences
Introduction
A western lifestyle is characterised by regular consumption 
of readily available energy-dense foods [1], often paired 
with sedentary behaviour throughout the day [2] and/or 
minimal amounts of exercise [3]. These behavioural pat-
terns are associated with an increased risk of obesity, type 2 
diabetes (T2D) and cardiovascular disease [4–6]. At present, 
cardiovascular disease is established as the leading cause of 
mortality in western countries [7] and T2D vastly increases 
the risk of cardiovascular complications [8].
Insulin resistance is defined as impaired insulin-stimu-
lated glucose uptake in skeletal muscle and adipose tissue 
stores often combined with impaired insulin-induced sup-
pression of hepatic glucose production. Both hepatic and 
skeletal muscle insulin resistance are central to the develop-
ment of T2D [9] [10]. Metabolic flexibility is closely linked 
with skeletal muscle insulin sensitivity [11], and is defined 
as the capacity to switch from high rates of lipid oxidation in 
the fasted state to an increased rate of carbohydrate oxidation 
under insulin-stimulated conditions [12]. Metabolic flexibil-
ity is often diminished in obese insulin-resistant individuals 
in comparison to the lean insulin-sensitive state [13].
Whilst obesity itself is commonly associated with insulin 
resistance and T2D [14], it is now clear that distinct fat pat-
terning is more closely related with disease risk [15]. For 
example, fat accumulation in the abdominal region, and in 
particular visceral fat, is strongly related to metabolic dis-
ease and systemic inflammation [16–19], whilst peripheral 
adipose tissue located in the gluteal–femoral regions appears 
to be protective against metabolic disease [20]. Abdominal 
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adiposity is a typical feature of the male population, with 
females tending to accumulate fat in the gluteal–femoral 
region [21]. These differences in adipose tissue storage 
between sexes likely underpin the sex differences in the risk 
for developing metabolic disease. Epidemiological studies 
have shown that the incidence of T2D and cardiovascular 
disease is lower in females compared to males [7, 22, 23]. 
Large cross-sectional studies have also shown that males 
(35–65 years) have a higher prevalence (+ 1.3–1.9%) of 
elevated fasting glucose in comparison to females [24, 25]. 
In another cross-sectional study, males (18–32 years) had a 
reduced blood glucose clearance capacity (− 15%) following 
an intravenous glucose tolerance test compared to females 
[26]. Smaller clinical trials investigating insulin sensitivity 
in BMI and age-matched males and pre-menopausal females 
(20–45 years) using a hyperinsulinaemic euglycaemic (HE) 
clamp have established that females exhibit a similar or 
higher glucose infusion rate per kilogram of body weight 
(+ 36–47%) when compared to males [27–31], and a mark-
edly higher glucose infusion rate when adjusted per kilo-
gram of lean mass (45–98%) [28, 31].
Despite females being at a reduced risk of developing 
insulin resistance and cardio-metabolic disease, there is lit-
tle research investigating the differences in the progression 
of insulin resistance and negative cardio-metabolic health 
between the sexes. One approach to investigate this is to 
provide excess lipid through an acute lipid infusion during 
a HE clamp, and it has been shown that a 7 h lipid infusion 
caused less of a reduction in glucose infusion in females 
(26%) in comparison to males (38%) [32].
Excess lipid exposure from infusion studies may only 
illustrate acute physiological responses, whereas more pro-
longed consumption of a high-fat high-calorie (HFHC) diet 
provides a chronic stimulus to investigate the influence of 
increased fat and energy intake (creating a positive energy 
balance) on adipose tissue stores and early abnormalities 
in metabolic and cardiovascular regulation. In healthy indi-
viduals, consumption of a HFHC diet for 5–7 days has been 
demonstrated to reduce hepatic insulin sensitivity (− 65%) 
[33] and peripheral insulin sensitivity (− 20%) [34] during 
a HE clamp. HFHC diets also reduced whole-body insulin 
sensitivity (− 27%) measured with an oral glucose toler-
ance test [35] or glucose tolerance (− 11%) measured after 
ingestion of a mixed meal (112 g carbohydrate in a 771 kcal 
meal) [36]. Although some of these studies have included 
female participants [35, 36], to date, no study has directly 
compared sexes to identify the sex-specific cardiovascular 
and metabolic responses to a short-term HFHC diet. This is 
a considerable oversight considering females, compared to 
males, exhibit higher insulin sensitivity and tend to store fat 
peripherally, rather than centrally, and therefore appear to 
be better protected against metabolic disease. Establishing 
whether females are better equipped to handle lipid overload 
from a 7-day HFHC diet will be beneficial in underpinning 
the pathology of T2D in this understudied cohort. Conse-
quently, the aim of this study was to investigate the hypoth-
esis that females matched for age, BMI, cardio-respiratory 
fitness and habitual activity levels are better protected than 
males in developing insulin resistance induced by a HFHC 
diet. We also aim to underpin sex-specific differences in 
metabolic and cardiovascular functional outcomes (fat 
mass accumulation, metabolic flexibility, arterial stiffness 
and blood lipid and liver concentrations) in response to the 
7-day HFHC diet.
Methods
Subjects and ethical approval
A cohort of young healthy males (n = 11) and females 
(n = 11) were matched for BMI (kg.m−2), age and  VO2 peak 
[ml.min−1.kg (fat-free mass (FFM))−1] (see Table 1 for char-
acteristics).  VO2 peak was adjusted to FFM to remove the 
influence of increased fat mass on body mass observed in 
the female cohort allowing for direct comparison of sexes. 
The sample size for this experiment was estimated based 
on previous literature that showed a reduction in glucose 
tolerance or insulin sensitivity following 7 days of a high-
fat (65% energy) high-calorie diet (+ 50% kcal) [35, 36]. 
Written informed consent was obtained from all participants. 
The study protocol adhered to the Declaration of Helsinki 
and was approved by NHS West Midlands, Black Coun-
try Research Ethics Committee. All participants were free 
from cardiovascular or metabolic disorders, physically 
active (exercising at least 3 times per week for more than 
30 min at a time) and non-smokers. Additionally, females 
were required to have a regular menstrual cycle, not be 
pregnant or breast-feeding during the study and only using 
the following contraceptive methods; condoms, diaphragm, 
Table 1  Participants characteristics
Data provided as mean ± SD
BMI body mass index, FM fat mass, FFM fat-free mass, ISI insulin 
sensitivity index
*Significant difference between sexes P < 0.05
Males Females
n 11 10
Age (years) 24 ± 4 25 ± 4
Body mass (kg)* 72.6 ± 5.3 63.9 ± 9.5
BMI (kg.m−2) 23 ± 2 23 ± 2
V ࡆO2 peak (L.min−1)* 3.60 ± 0.59 2.51 ± 0.48
VࡆO2 peak (ml.min−1.kgFFM−1) 62.3 ± 8.7 58.2 ± 8.2
Matsuda ISI 11.6 ± 10.5 9.2 ± 3.4
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IUD (intrauterine device), combined pill. Due to the nature 
of the dietary intervention, vegetarians and vegans were 
excluded from participation. During the dietary interven-
tion, one female participant withdrew from participation due 
to gastro-intestinal discomfort and, therefore, her data were 
withdrawn from the analyses. Withdrawal of this participant 
did not affect the group matching of sexes.
Pre-experimental procedures
Prior to the start of the study, participants attended the 
laboratory following an overnight fast (≥ 10 h) for baseline 
assessments of body composition, resting energy expendi-
ture (REE) and  VO2 peak (Fig. 1). Body composition was 
measured using whole-body fan beam dual-energy X-ray 
absorptiometry (DEXA) (Hologic QDR Series, Discovery 
A, Bedford, MA, USA). Following removal of jewellery 
and metal objects, participants were scanned (~ 180 s) in a 
supine position. Each scan was automatically analysed with 
the QDR software; however, the operator manually corrected 
the trunk and limb regions and an area identifying visceral 
adipose tissue (VAT). Percentage body fat (%), total body fat 
(kg) and FFM (kg) are presented as subtotal values exclud-
ing head measurements to reduce measurement error.
Following the DEXA scan, participants’ REE was 
measured using a Moxus Modular Metabolic system 
(AEI Technologies, IL, USA). Participants were required 
to lay in a supine position in a dark room for 10 min 
before the Moxus ventilation hood was placed over their 
head and shoulders for a further 20 min. Volume flow 
rate was maintained above 25 L.min−1. The first 5 min 
of data was discarded according to best practice methods 
[37]. REE was calculated towards the end of the 20 min 
period, averaged over a 5 min stable period where coef-
ficient of variation for  VO2 and  VCO2 was ≤ 10%. REE 
(kcal/min) was calculated using the Weir equation where 
REE (kcal∕min) =
(
3.94 × VO2
(
L.min
−1
))
+
(
1.11 × VCO2
(
L.min
−1
)) 
[38]. This number was then used to calculate REE (Kcal/
day) over an entire day.
Participants also performed a progressive exercise test 
to exhaustion on an electronically-braked cycle ergom-
eter (Lode Corival, Lode B.V, Groningen, Holland) to 
determine  VO2 peak using the Moxus Modular Metabolic 
system (AEI Technologies, IL, USA). The test consisted 
of cycling initially at 60 W, followed by sequential incre-
ments of 35 W every 3 min until cadence was reduced 
to < 50  rpm, at which point the test was terminated. 
 VO2 peak (L.min−1) was taken as the highest value obtained 
in the last 30 s of the test. This value was then expressed 
relative to fat-free mass (FFM) (kg) obtained from the 
DEXA scan to give a  VO2 peak (ml.min−1. kg (FFM)−1) 
normalised for fat-free mass body weight allowing males 
and females to be compared directly.
Following pre-experimental testing, participants were 
provided with a 3-axis activity monitor (wGT3X-BT, Acti-
Graph, Pensacola, FL, USA) and a food diary to record 
habitual activity levels and food intake, respectively. Par-
ticipants were advised to continue habitual activity levels 
whilst wearing the activity monitor on their right waist for 
a duration of 3 days (2 weekdays and 1 weekend day). Par-
ticipants were provided with detailed written and verbal 
instructions on how to complete the 3-day food diary (2 
weekdays and 1 weekend day), including information on 
quantity, food preparation, brand information and cook-
ing methods. Habitual diets were later analysed manually 
for total daily intake (kcal) and macronutrient breakdown 
(Table 2).
Fig. 1  Schematic diagram of 
study design. DEXA dual-
energy X-ray absorptiometry, 
OGTT oral glucose tolerance 
test, PA physical activity, REE 
resting energy expenditure
7- day High fat high calorie diet
PA monitoring during diet 
Pre-experimental 
procedures
• DEXA
• REE
• VO2 peak
-7
Baseline testing
• Arterial stiffness
• DEXA
• OGTT
• Metabolic Flexibility 
Post-intervention testing
• Arterial stiffness
• DEXA
• OGTT
• Metabolic Flexibility 
Day 0 8
Habitual PA monitoring
Habitual diet
Table 2  Estimated energy requirements and actual HFHC energy 
intakes
Data provided as mean ± SD
TEE total energy expenditure
Males (n = 11) Females (n = 10)
Self-reported habitual intake 
(kcal)
2639 ± 453 2193 ± 407
Self-reported diet fat intake (%) 33 ± 2 34 ± 7
Estimated TEE (kcal) 2653 ± 407 2259 ± 349
Required HFHC intake (kcal) 3979 ± 610 3389 ± 523
Actual HFHC intake (kcal) 4063 ± 669 3464 ± 357
HFHC diet fat intake (%) 65 ± 1 65 ± 1
HFHC diet saturated fat intake (% 
of overall fat)
37 ± 3 37 ± 2
 European Journal of Nutrition
1 3
Experimental design
Participants were advised to consume their habitual diet 
7 days prior to pre-testing. Experimental testing was con-
ducted pre- and post-7-day HFHC diet (Fig. 1). Pre-testing 
for female participants occurred between days 1–6 of the 
menstrual cycle (follicular phase) to minimise the impact 
of fluctuations of sex hormones on the results. Participants 
attended the laboratory following an overnight fast (≥ 10 h) 
after abstaining from caffeine, alcohol and vigorous exercise 
the day before testing. The following measurements were 
conducted pre- and post-HFHC diet intervention in addition 
to a DEXA scan, as previously described.
Arterial sti"ness
Participants rested in a supine position for 15 min before 3 
brachial artery blood pressure measurements were conducted 
using an automated sphygmomanometer (GE CARESCAPE 
V100-1 Patient monitor, GE Healthcare, Chicago, USA). 
Arterial stiffness was measured using central (carotid– femo-
ral) pulse wave velocity (aPWV) using a semi-automated 
device and software (SphygmoCor, AtCor Medical, Syd-
ney, Australia) as previously described [39]. Systemic wave 
reflection was investigated using pulse wave analysis to pro-
duce an augmentation index with the semi-automated device 
and software (SphymoCor; [39]). The augmentation index 
was normalised to a heart rate of 75 bpm  (AIx@75 bpm) to 
account for confounding influence of heart rate. All meas-
urements were made in triplicate.
Oral glucose tolerance test
A 20G cannula (BD Venflon™, BD, Oxford, England) was 
inserted into an antecubital vein to allow for repeated blood 
sampling during the oral glucose tolerance test (OGTT). A 
10 ml blood sample was obtained at baseline before partici-
pants consumed a 75 g glucose drink made with 225 ml of 
water. Subsequent blood samples (10 ml) were obtained at 
15, 30, 45, 60, 90 and 120 min following glucose ingestion. 
Blood samples were divided equally between vacutainers 
containing EDTA or a clotting agent (silicon and micronized 
silica) (BD, Oxford, England) to allow for the separation 
of plasma and serum, respectively. Prior to centrifugation, 
EDTA tubes were stored on ice, whereas serum tubes were 
left at room temperature until clotting had occurred. Blood 
tubes were centrifuged at 1000 g for 10 min at 4 °C before 
being stored at – 80 °C for subsequent analysis.
Metabolic #exibility
Prior to the OGTT, participants rested in a supine position 
for 20 min in a dark room with a ventilation hood placed 
over their head and shoulders (Moxus Modular Metabolic 
System, AEI Technologies, IL, USA).  VO2 and  VCO2 were 
measured from the collected expired air and used to calcu-
late the respiratory exchange ratio (RER). The first 5 min 
of data was discarded according to best practice methods 
[37]. Fasting RER was averaged over a 5 min stable period 
where coefficient of variation for  VO2 and  VCO2 was ≤ 10%. 
The Moxus ventilation hood was removed for a brief period 
(≤ 2 min) to allow participants to consume the glucose bev-
erage before being returned over their head and shoulders 
for the remainder of the OGTT. The Moxus volume flow rate 
was maintained at > 25 L.min−1. For the remaining OGTT, 
RER was averaged over 5 min intervals. Peak RER follow-
ing glucose ingestion was identified as the maximum RER 
obtained at any 5 min interval during the 120 min OGTT. 
The time that peak RER was obtained was recorded and used 
in the following equation to calculate metabolic flexibility.
Blood analyses
Serum samples were analysed for glucose (all time points 
during OGTT) and fasting non-esterified fatty acids (NEFA), 
triglycerides, cholesterol, aspartate aminotransferase (AST), 
alanine aminotransferase (ALT) and gamma-glutamyltrans-
ferase (GGT) concentrations using commercially available 
spectrophotometric assays (Randox) with a semi-automatic 
analyser (Randox Daytona RX, Randox, Crumlin, UK). 
Plasma samples from the OGTT were analysed for insulin 
concentrations with a commercially available direct insulin 
ELISA kit (Fisher Scientific, Loughborough, UK).
Calculations
Glucose area under the curve (AUC) and insulin AUC dur-
ing the OGTT were calculated using the trapezoidal rule 
with zero as baseline.
Whole-body insulin sensitivity was calculated using the 
Matsuda insulin sensitivity index (ISI) [40] with the follow-
ing equation;
Hepatic and muscle insulin resistance indexes were esti-
mated using the following equations from Abdul-Ghani et al. 
[41];
Metabolic flexibility =
Peak RER − Fasting RER
Time to reach peak RER
Matsuda ISI =
10, 000
√
(FPG × FPI) × (MPG ×MPI)
Hepatic insulin resistance index = PG AUC0−30min × PI AUC0−30min
Muscle insulin resistance index = dG∕dt ÷MPI
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where FGP is fasting plasma glucose, FPI is fasting plasma 
insulin, MPG is mean plasma glucose during the OGTT, 
MPI is mean plasma insulin during the OGTT, PG AUC 
0–30 min is plasma glucose area under the curve from 0 to 
30 min, PI AUC 0–30 min is plasma insulin area under the 
curve from 0 to 30 min and dG/dt is rate of change in plasma 
glucose from its peak to its nadir.
Seven day HFHC diet
Although habitual dietary intake was assessed (Table 2), 
there are known issues with participants under-reporting 
food intake [42] and therefore the energy value of the 
HFHC was determined based on REE and physical activ-
ity levels. The participants were highly active, as meas-
ured objectively by accelerometry and subjectively by the 
International Physical Activity Questionnaire (IPAQ) [43]. 
As fitness and activity levels were similar between sexes, 
the same activity factor of 1.7 was multiplied by REE for 
both males and females to calculate total energy expendi-
ture (TEE), before being multiplied by 1.5 to calculate 
each individual’s energy intake required during the HFHC 
diet (Table 2). The diets were designed so that fat contrib-
uted 65% of total energy intake, with approximately 37% 
of fat intake derived from saturated fat. The remaining 
energy was provided from carbohydrate (~ 17%) and pro-
tein (~ 18%). All food was purchased and provided by the 
research team, in addition to a set of scales provided to the 
participants so all food items could be weighed correctly. 
Food for the diet was selected such that it would require 
minimal preparation and cooking by each participant. 
Where cooking was required, participants were given strict 
instructions on how to cook the food and were provided 
with the quantity of cooking oil/butter where necessary.
To increase compliance to the diet, all participants were 
provided with a HFHC diet plan prior to the intervention 
to ensure palatability with all foods. Participants were 
instructed of the importance to consume all food on their 
HFHC dietary plan and to not consume any other food 
products. Participants were advised to report and return 
any food items that they could not consume during the diet 
so that energy intake and macronutrient percentage could 
be adjusted as necessary. All participants were required 
to record the food items and note the time they consumed 
them in an individual food diary. Each participant was 
instructed to continue their habitual physical activity (PA) 
levels and wore the 3-axis activity monitor (wGT3X-BT, 
ActiGraph, Pensacola, FL, USA) to ensure habitual PA 
levels remained constant.
Statistics
An independent t test was used to confirm equal matching of 
male and female participants for age, BMI and  VO2 peak [ml.
min−1.kg (FFM)−1]. All metabolic and cardiovascular func-
tional outcomes were analysed using a two-factor repeated 
measures ANOVA, with the between-subjects-factor ‘sex’ 
(males vs. females) and within-subjects-factor ‘HFHC diet’ 
(pre- vs. post-diet). Significant main effects and interac-
tions were assessed post hoc using Bonferroni adjustment 
analysis.
Results
Subject characteristics
At baseline, there was no significant difference between 
males and females for age, BMI and  VO2peak (ml.min−1.
kg (FFM)−1) (P > 0.05; Table 1). Of the females who com-
pleted the HFHC diet, 4 were using the combined pill con-
traceptive method.
Energy intake and macronutrient composition 
during the HFHC diet
All participants returned their HFHC diet plan with confir-
mation of times that they had consumed the food through-
out the 7 days. All participants adhered to the HFHC diet 
and any food that was not consumed by the participants was 
notified to the researchers and returned to the laboratory to 
allow HFHC diet calculations to be adjusted. Both sexes 
consumed an equal proportion of dietary fat as saturated fat 
(Table 2). All participants continued their habitual exercise 
regime throughout the 7-day HFHC diet period. Average 
daily physical activity energy expenditure calculated from 
the 3-axis activity monitor (wGT3X-BT, ActiGraph, Pensa-
cola, FL, USA) revealed no significant differences between 
habitual physical activity levels (535 ± 224 kcal) and during 
the HFHC (510 ± 229 kcal) for either sex (P = 0.552).
Body composition
Prior to the HFHC diet (baseline), males had significantly 
higher body mass than females (P < 0.009), but there was 
no effect of the HFHC diet on body mass for either sex 
(P = 0.121). Although matched for BMI, at baseline, females 
had a significantly higher body fat percentage (P < 0.001) 
and total fat mass (P = 0.003; Table  3). Conversely at 
baseline, males had significantly higher FFM (P < 0.001), 
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visceral fat (P < 0.001) and a higher trunk to leg fat mass 
ratio (P < 0.001), whereas trunk fat mass was not different 
between sexes (P = 0.101; Tables 2 and 3). Following the 
HFHC diet, there was a trend towards an increase in total fat 
mass (P = 0.056) which was similar for males (+ 1.8%) and 
females (+ 2.3%; Table 3). Following the HFHC diet, there 
was a significant increase in trunk to leg fat mass ratio in 
males only (+ 5.1%; HFHC diet x sex interaction, P = 0.039, 
Table 3). After the HFHC, there were no alterations in FFM, 
body fat percentage, visceral fat or trunk fat mass in either 
sex.
OGTT 
At baseline, fasting plasma glucose concentrations were 
similar between males (4.3 ± 0.6 mmol.L−1) and females 
(4.2 ± 0.4 mmol.L−1 L; P = 0.766) and after the HFHC diet, 
fasting glucose did not change in either sex. There were no 
differences in fasting serum insulin concentrations between 
males (7.1 ± 3.9 μlU.mL−1) and females (7.5 ± 4.0 μlU.
mL−1; P > 0.05) and this did not change following the HFHC 
diet in either sex. Plasma glucose AUC and insulin AUC 
during the OGTT were not significantly different between 
sexes (P > 0.05) and not altered following the HFHC diet in 
either sex (P > 0.05; Fig. 2).
Insulin sensitivity
In an attempt to decipher changes in insulin sensitiv-
ity dependent on origin (liver or muscle), glucose and 
insulin values from the OGTT were also used to predict 
hepatic and muscle insulin resistance using the calcula-
tions proposed by Abdul-Ghani et al. [41], in addition to 
the Matsuda ISI (46), which is a measure of whole-body 
insulin sensitivity. At baseline, there were no significant 
differences between sexes for the Matsuda ISI (P = 0.844), 
hepatic insulin resistance (P = 0.211) or muscle insulin 
resistance (P = 0.584; Fig. 3). After the HFHC diet, there 
were no significant changes in any of the aforementioned 
measures of insulin sensitivity in males nor females 
(Fig. 3).
Metabolic #exibility
At baseline, there were no significant differences in fasting 
RER between males (0.81 ± 0.07) and females (0.76 ± 0.08; 
P = 0.189). Following the HFHC diet, there was a trend 
towards a reduction in fasting RER, which was reduced 
similarly between males and females post-HFHC diet 
(0.78 ± 0.08 and 0.74 ± 0.07 for males and females, respec-
tively; P = 0.052). At baseline, peak RER during OGTT 
was similar between males (0.94 ± 0.07) and females 
(0.91 ± 0.16; P = 0.629). Following the HFHC diet, there 
was a trend towards a reduction in peak RER for males 
(0.91 ± 0.07) and females (0.86 ± 0.08; P = 0.070). The 
time it took to reach peak RER during the OGTT was simi-
lar between males (88 ± 6 min) and females (90 ± 7 min; 
P = 0.644) and this did not change after the HFHC diet.
Metabolic flexibility was determined as the rate of change 
from fasting RER to peak RER during the OGTT. At base-
line, there was no significant difference between males and 
females for metabolic flexibility (P = 0.877) and this was 
unaltered following the HFHC diet in both sexes (P > 0.05; 
Fig. 4a).
Arterial sti"ness
AIx@75 bpm was not significantly different at baseline 
between sexes (P = 0.162) and was unaltered following the 
Table 3  Effect of 7-days HFHC 
diet on body composition
Data are provided as mean ± SD
BMI body mass index, FM fat mass, FFM fat-free mass, VAT visceral adipose tissue
*Significant difference vs. females at baseline P < 0.05
‡ Significant interaction effect P < 0.05
Males Females
Pre (n = 11) Post (n = 11) Pre (n = 10) Post (n = 10)
Body mass (kg) 72.9 ± 4.9* 73.2 ± 5.2 63.7 ± 9.3 63.9 ± 2.9
BMI (kg.  m−2) 23.2 ± 1.4 23.3 ± 1.4 23.2 ± 1.5 22.8 ± 2.4
FM (kg) 11.7 ± 3.1* 11.9 ± 3.0 17.3 ± 4.1 17.7 ± 4.0
FFM (kg) 58.6 ± 5.5* 57.9 ± 1.2 43.2 ± 5.9 40.3 ± 10.0
Body fat (%) 16.8 ± 4.0* 16.9 ± 3.8 28.4 ± 3.6 29 ± 3.3
Trunk fat mass (kg) 5.4 ± 1.4 5.6 ± 1.4 6.7 ± 2.0 6.6 ± 2.0
Trunk/leg fat ratio 0.87 ± 0.13* 0.92 ± 0.17‡ 0.63 ± 0.09 0.63 ± 0.09
VAT (g) 308 ± 45* 295 ± 47 174 ± 71 177 ± 22
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HFHC diet (P = 0.318; Fig. 3b). aPWV was also not signifi-
cantly different at baseline between sexes (P = 0.826) and 
was unaltered after the HFHC diet (P = 0.307; Fig. 4c).
Serum lipids and liver enzymes
At baseline, there were no significant differences between 
sexes for serum NEFA (P = 0.912), cholesterol (P = 0.878) 
and triglycerides (P = 0.315; Table 4). After the HFHC diet, 
there was a significant increase in cholesterol (P = 0.049) 
which was similar between males (+ 8.1%) and females 
(+ 6.3%; Table 4). Triglyceride and NEFA concentrations 
remained unchanged following the HFHC diet for both sexes 
(P = 0.685; Table 4).
Circulating liver enzymes AST, ALT and GGT were 
used as markers of liver damage. At baseline, there was no 
significant difference in AST concentration between sexes 
(P = 0.152); however, males had significantly higher ALT 
concentrations (P = 0.006) which resulted in lower AST/ALT 
ratio compared to females (P = 0.009). There was also a trend 
towards higher GGT concentrations in males compared to 
females (P = 0.059; Table 4). After the HFHC diet, there were 
no significant changes in levels of AST, ALT, AST/ALT ratio 
or GGT in either sex (P > 0.05; Table 4).
Fig. 2  Effect of 7-days HFHC 
diet on glucose and insulin val-
ues during an OGTT in males 
and females. No sex differences 
or effects of the HFHC diet 
on serum glucose levels (a) or 
plasma insulin values (b) during 
the OGTT. The AUC during the 
OGTT shows no sex differ-
ences or effects of the HFHC 
diet for serum glucose (c) or 
plasma insulin (d). For AUC 
graphs (c and d) solid black line 
represents mean value whereas 
dashed lines show individual 
responses
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Discussion
This is the first study in humans to investigate sex differ-
ences in measurements of metabolic and cardiovascular 
health indicators in response to a 7-day HFHC diet. The 
results show there was no effect of the HFHC diet on meta-
bolic and cardiovascular outcome measures in either sex. 
This highlights that young, physically active humans of 
both sexes who have good levels of cardio-respiratory fit-
ness can tolerate a 7-day HFHC diet without measurable 
impairments in metabolic or cardiovascular health.
Of the metabolic and cardiovascular functional outcomes 
measured, the only variables that changed in both sexes 
were body fat and total cholesterol. We are the first to study 
and quantify changes in fat mass following a short-term 
(5–7 day) HFHC diet and determine sex-specific changes 
in a well-matched cohort. The results suggested a trend 
towards an increase in body fat following the HFHC diet 
which occurred in both sexes. In comparison to total adipos-
ity, abdominal adiposity and in particular elevated visceral 
fat, are more closely associated with insulin resistance and 
T2D [22, 44]. In line with previous findings [45–47], at 
Fig. 3  Effect of 7-days HFHC 
diet on indices of insulin sen-
sitivity measured with OGTT. 
No sex differences or effects 
of HFHC diet were seen on 
the Matsuda index (a), hepatic 
insulin resistance index (b) and 
muscle insulin resistance index 
(c) in males and females. Solid 
black line represents mean value 
whereas dashed lines show 
individual responses. Matsuda 
index was derived from Mat-
suda and DeFronzo [40] whilst 
hepatic and muscle insulin 
resistance indexes were derived 
from Abdul-Ghani et al. [41]
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baseline visceral fat stores were higher in males compared 
to females, but this did not change following the HFHC diet. 
Trunk fat measured by the DEXA scan represents overall 
abdominal adiposity rather than specific visceral fat. There 
were no differences between males and females at baseline 
for trunk fat and following the HFHC diet trunk fat was not 
changed, but there was an increase in trunk to leg fat mass 
ratio which increased only in males (Table 3). This change 
in unfavourable fat accumulation ratio occurred after only 
7 days of a HFHC diet but without any decrements in insu-
lin sensitivity. It is likely that more chronic positive energy 
balance would exacerbate this fat accumulation in males 
and start to contribute to the development of metabolic 
disorders.
There was a trend towards a decrease in fasting RER fol-
lowing the HFHC diet with the difference between the sexes 
not being apparent. There was a large variability between 
participants and given the large reduction observed in RER, 
significance would have likely been observed if a larger 
cohort had been studied. Obese insulin-resistant individu-
als have previously been shown to exhibit lower metabolic 
flexibility in comparison to lean insulin-sensitive individuals 
[13]. In our study, metabolic flexibility was measured as the 
rate of change from fasting RER to peak RER during the 
OGTT. As there were no measurable changes from baseline 
following the 7-day HFHC diet in either sex, this indicates 
that both the females and the males were able to maintain 
metabolic flexibility. The current study is the only work to 
Fig. 4  Effect of 7-days HFHC 
diet on metabolic and cardio-
vascular functional outcomes. 
No sex differences or effects 
of HFHC diet were observed 
on metabolic flexibility (Peak 
RQ−Fasting RQ)/dt) (a), arte-
rial stiffness (aPWV) (b) and 
augmentation index (@ 75 bpm) 
(c) in males and females. Solid 
black line represents mean value 
whereas dashed lines show 
individual responses
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investigate and show no sex differences in metabolic flex-
ibility following a HFHC diet in young healthy active indi-
viduals. Whilst metabolic inflexibility is a characteristic of 
insulin-resistant states, our data suggest metabolic flexibility 
is unlikely to be compromised following an acute insult of 
high-fat caloric excess in individuals with high cardio-res-
piratory fitness.
Overall, 7 days of HFHC diet did not induce changes in 
whole-body insulin sensitivity (Matsuda ISI), or indices of 
hepatic or muscle insulin resistance. This was somewhat 
surprising considering previous studies have reported a 
reduction in measurements of insulin sensitivity following 
the same 7-day HFHC diet in young, healthy lean individu-
als [35, 36, 48, 49]. The current study was novel, however, in 
measuring and characterising high cardio-respiratory fitness 
and high physical activity levels of the participants. Longitu-
dinal studies have shown that high cardio-respiratory fitness 
can reduce the risk of T2D [50] and all-cause mortality [51]. 
Furthermore, it has been shown that high cardiorespiratory 
fitness reduces the risk of all-cause mortality in males who 
have a high BMI in comparison to males who have a nor-
mal BMI but have low cardio-respiratory fitness [52]. Low 
cardio-respiratory fitness is, therefore, established as an 
independent risk factor for all-cause mortality and may be a 
stronger risk factor than increased adiposity. We propose the 
high cardio-respiratory fitness the current cohort possessed 
may have protected them from the negative effects imposed 
from the 7-day HFHC diet in this study. To investigate this, 
future research should compare the metabolic and cardiovas-
cular responses to a HFHC diet in young healthy lean par-
ticipants with either low or high cardio-respiratory fitness. 
This study was also unique in considering the physiologi-
cal variable of sex on the effects a HFHC diet by matching 
male and female cohorts for age, BMI and cardiorespiratory 
fitness. We show for the first time there were no sex differ-
ences in their response to a HFHC diet when young, healthy 
participants are investigated.
This was the first study to measure arterial stiffness 
response to a HFHC diet. Here, it was demonstrated that 
similar to insulin sensitivity, a 7-day HFHC diet does not 
appear to be of sufficient duration to impair this cardiovas-
cular functional outcome measure in either sex of young 
healthy participants. There were also no increases in the 
circulating concentrations of liver enzymes, AST, ALT and 
GGT which are early biomarkers of lipid accumulation in 
the liver [53]. It should be noted that males had a higher 
ALT concentration resulting in a lower AST/ALT ratio at 
baseline and after the HFHC diet. Elevated ALT is associ-
ated with fatty liver and non-alcoholic fatty liver disease 
but does not define a specific disease [54]. The reported 
upper limit of normal of ALT varies greatly between labo-
ratories and sexes (35–79 U.L−1 for males and 31–55 U.L−1 
for females) [55], and although it is established that healthy 
males have higher ALT concentrations compared to healthy 
females [56], the mechanisms underpinning this differences 
are unknown [57]. The two-fold greater ALT concentration 
in males compared to females in the present study reflects 
the available epidemiological data [54–57] but is not ele-
vated to an extent which might suggest signs of NAFLD. 
We anticipated to see increases in the plasma concentra-
tion of both triacylglycerol and fatty acids as markers of 
lipid overload; however, none of these plasma lipid con-
centrations increased following the HFHC diet in either sex 
(Table 4). We did, however, observe a significant increase 
in the plasma total cholesterol concentration in both sexes 
following the 7-day HFHC diet (Table 4), contradicting pre-
vious findings showing no change in total cholesterol follow-
ing 5-day HFHC diet in males only [33]. Unfortunately, we 
Table 4  Effect of 7-days HFHC 
diet on serum lipids and liver 
enzymes
Data are provided as mean ± SD
ALT alanine aminotransferase, AST aspartate aminotransferase, GGT Gamma-glutamyltransferase
*Significant difference vs. females at baseline P < 0.05
† Significant main effect for the HFHC diet P < 0.05
Males Females
Pre (n = 11) Post (n = 11) Pre (n = 10) Post (n = 10)
Serum Lipid concentrations
 NEFA (mmol.L−1) 1.16 ± 0.43 1.05 ± 0.25 1.17 ± 0.26 1.37 ± 0.46
 Cholesterol (mmol.L−1) 3.56 ± 0.86 3.85 ± 0.63† 3.95 ± 0.59 4.20 ± 0.58†
 Triglycerides (mmol.L−1) 0.81 ± 0.92 0.70 ± 0.45 0.51 ± 0.17 0.59 ± 0.25
Liver enzymes
 AST (U.L −1) 35.82 ± 7.86 34.64 ± 13.66 28.10 ± 4.52 28.25 ± 17.77
 ALT (U.L−1) 35.36 ± 19.80* 35.05 ± 16.77 16.15 ± 7.35 16.80 ± 7.30
 AST/ALT ratio 1.17 ± 0.43* 1.08 ± 0.39 1.75 ± 0.47 1.62 ± 0.36
 GGT (U.L−1) 21.65 ± 11.87 21.13 ± 8.41 15.28 ± 12.15 11.56 ± 5.39
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were unable to interrogate this further to understand whether 
these increases were due to changes in HDL and/or LDL 
cholesterol.
Obesity is often associated with reduced PA levels and 
consumption of HFHC diets. A recent systematic review 
concluded that HFHC diet studies can often influence par-
ticipant’s PA levels, which may impact changes in weight 
gain [58]. In the current study, all participants exhibited high 
habitual PA levels with the IPAQ and this was largely due 
to participants participating in regular structured exercise. 
Participants continued their regular exercise regime through-
out the 7-day HFHC diet period and habitual daily energy 
expenditure measured with accelerometry was the same 
before and during the diet period. This, in addition to good 
levels of cardio-respiratory fitness could explain why both 
male and female participants in our study were able to com-
pensate for the potential negative effects of the 7-day HFHC 
diet. Another study showed that the combination of both 
reduced PA and HFHC diet led to larger (significant) reduc-
tions in insulin sensitivity in healthy young males [59]. A 
limitation of the present study is that only young participants 
with good levels of cardio-respiratory fitness were recruited. 
Further work is now required to determine whether good 
levels of cardio-respiratory fitness in both young and older 
adults compensates the effects of a HFHC.
In summary, this study observed no main effects of a 
7-day HFHC diet on metabolic and cardiovascular functional 
outcomes in lean young healthy individuals of either sex 
with high levels of cardio-respiratory fitness. More research 
needs to be conducted to examine if the high cardio-respira-
tory levels protected both sexes from the expected negative 
effects of the HFHC diet. Despite participants maintaining 
high levels of PA, the male cohort did experience an increase 
in trunk to leg fat mass ratio following the HFHC diet, which 
may be exacerbated with reduced PA. Although epidemio-
logical studies have shown that there is a reduced prevalence 
of insulin resistance and T2D in females, the underlying 
mechanisms of this sex difference are currently understud-
ied and not understood. We conclude that future research 
should investigate whether a repeat of the current study in 
males and females with a lower cardio-respiratory fitness 
will exacerbate the negative metabolic and cardiovascular 
functional outcomes and thus reveal the mechanisms leading 
to a higher T2D risk in males than in females.
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